Standard BioTools to Participate in Upcoming Investor Conferences
14 Junho 2023 - 8:30AM
Standard BioTools Inc. (Nasdaq: LAB), driven by a bold purpose
– Unleashing tools to accelerate breakthroughs in human health
– today announced Company management will participate in the
following investor conferences:
- Capital One
Securities 2nd Annual Spatial Biology and Proteomics Virtual
Research Summit: On Tuesday, June 20, at 10:30 am ET,
David King PhD, Senior Vice President, Global Research and
Development, will participate in the “Pushing the Envelope of
Technology with Increased Sensitivity and Higher Plex on the
Horizon” Panel. Dr. King will also participate in a company
presentation at 2:35 pm ET.
- TD Cowen 2nd
Annual Tools/Dx Revolution: On Monday, June 26, at 4:20 pm
PT, Michael Egholm, President and Chief Executive Officer, will
participate in the “Spatial – The Next Frontier: Clinical”
Panel.
Due to the format of these events, webcasts will not be
available. Presentation materials will be available on the Investor
Relations page of the company’s website at Events &
Presentations.
About Standard BioTools Inc.
Standard BioTools Inc. (Nasdaq: LAB), previously known as
Fluidigm Corporation, is driven by a bold purpose – Unleashing
tools to accelerate breakthroughs in human health. Standard
BioTools has an established portfolio of essential, standardized
next-generation technologies that help biomedical researchers
develop medicines faster and better. As a leading solutions
provider, the company provides reliable and repeatable insights in
health and disease using its proprietary mass cytometry and
microfluidics technologies, which help transform scientific
discoveries into better patient outcomes. Standard BioTools works
with leading academic, government, pharmaceutical, biotechnology,
plant and animal research, and clinical laboratories worldwide,
focusing on the most pressing needs in translational and clinical
research, including oncology, immunology, and immunotherapy. Learn
more at standardbio.com or connect with us on Twitter®, Facebook®,
LinkedIn®, and YouTube™. Standard BioTools, the Standard BioTools
logo, Fluidigm, the Fluidigm logo, and “Unleashing tools to
accelerate breakthroughs in human health” are trademarks and/or
registered trademarks of Standard BioTools Inc. or its
affiliates in the United States and/or other countries.
All other trademarks are the sole property of their respective
owners. Standard BioTools products are provided
for Research Use Only. Not for use in
diagnostic procedures.
Investor Contacts:
Scott R. Greenstone, CFAir@standardbio.com
Peter DeNardo 415 389
6400 ir@standardbio.com
Standard BioTools (NASDAQ:LAB)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Standard BioTools (NASDAQ:LAB)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024